Remnant Cholesterol Can Identify Individuals at Higher Risk of Metabolic Syndrome in the General Population

Overview

Journal Sci Rep

Specialty Science

Date 2023 Apr 12

PMID 37045908

Authors

Yang Zou

Maobin Kuang

Yanjia Zhong

Chunyuan Jiang

Affiliations

Soon will be listed here.

Abstract

Remnant cholesterol (RC) is a highly atherogenic lipid. Previous studies have shown that RC was closely associated with many metabolism-related diseases. However, the relationship of RC with metabolic syndrome (MetS) remains unclear. This study's objective is to investigate the relationship of RC with MetS. A total of 60,799 adults who received health assessments were included in this study. RC was calculated by subtracting the directly measured values for low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) from total cholesterol (TC) and divided into 5 groups according to its quintile. MetS diagnosis according to National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) definitions. Application of receiver operating characteristic (ROC) curve analysis and multivariate logistic regression to assess the association of RC with MetS. In RC quintile groups, the prevalence of MetS was 0.84, 1.10, 1.92, 3.87 and 37.71%, respectively. Multivariate logical regression analysis showed that RC and MetS maintained a stable independent positive correlation between both sexes. An interaction test further showed that the MetS risk associated with RC was significantly higher in women than in men. Moreover, ROC analysis results showed that RC had high accuracy in identifying MetS, especially among young and middle-aged men [(area under the curve: AUC) < 30 years: 0.9572, 30-39 years: 0.9306, 40-49 years: 0.9067]. The current study provided the first evidence of a positive association between RC and MetS, and that this correlation was stronger in women than in man, which may be due to the relative deficiency of estrogen in women.

Citing Articles

Association between RC/HDL-C and hyperuricemia in adults: evidence from NHANES 2005-2018.

Tai Y, Chen B, Kong Y, Wang X Front Endocrinol (Lausanne). 2025; 16:1514067.

PMID: 40065993 PMC: 11891044. DOI: 10.3389/fendo.2025.1514067.

Remnant cholesterol increases the risk of incident kidney stones: a nested case-control study in Chinese adults.

Wang D, Shi F, Zhang D, Wang H, Zhu Y, Wang J Urolithiasis. 2024; 52(1):160.

PMID: 39540945 DOI: 10.1007/s00240-024-01658-0.

Association between Remnant Cholesterol and Metabolic Syndrome among Chinese Adults: Chinese Nutrition and Health Surveillance (2015-2017).

Li F, Yuan H, Cai S, Piao W, Nan J, Yang Y Nutrients. 2024; 16(19).

PMID: 39408243 PMC: 11478903. DOI: 10.3390/nu16193275.

Gender-specific correlations between remnant cholesterol and severe abdominal aortic calcification in American adults.

Yan L, Hu X, Wu S, Zhao S Front Endocrinol (Lausanne). 2024; 15:1415424.

PMID: 39351538 PMC: 11439657. DOI: 10.3389/fendo.2024.1415424.

Nonlinear association between remnant cholesterol and reversion from impaired fasting glucose to normoglycemia: a multicenter cohort study.

Kong L, Wu Y, Yang H, Guo M, Zhong Y, Li J Lipids Health Dis. 2024; 23(1):303.

PMID: 39300559 PMC: 11414174. DOI: 10.1186/s12944-024-02286-8.

References

Xie G, Zhong Y, Yang S, Zou Y . Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study. Diabetes Metab Syndr Obes. 2021; 14:4735-4745. PMC: 8652915. DOI: 10.2147/DMSO.S341285. View

Cornier M, Dabelea D, Hernandez T, Lindstrom R, Steig A, Stob N . The metabolic syndrome. Endocr Rev. 2008; 29(7):777-822. PMC: 5393149. DOI: 10.1210/er.2008-0024. View

Greendale G, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K . Changes in body composition and weight during the menopause transition. JCI Insight. 2019; 4(5). PMC: 6483504. DOI: 10.1172/jci.insight.124865. View

Fujioka Y, Ishikawa Y . Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb. 2009; 16(3):145-54. DOI: 10.5551/jat.e598. View

Li C, Ford E, McBride P, Kwiterovich P, McCrindle B, Gidding S . Non-high-density lipoprotein cholesterol concentration is associated with the metabolic syndrome among US youth aged 12-19 years. J Pediatr. 2010; 158(2):201-7. DOI: 10.1016/j.jpeds.2010.07.050. View

Sun A, Ren J . Estrogen replacement therapy and cardiac function under metabolic syndrome: a treacherous art. Hypertension. 2012; 59(3):552-4. DOI: 10.1161/HYPERTENSIONAHA.111.186817. View

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

DeLong E, Delong D, Clarke-Pearson D . Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44(3):837-45. View

Sascau R, Clement A, Radu R, Prisacariu C, Statescu C . Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review. Nutrients. 2021; 13(6). PMC: 8224751. DOI: 10.3390/nu13061774. View

10.

Costas L, Sequera V, Quesada P, Altzibar J, Lope V, Perez-Gomez B . Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use. Menopause. 2015; 22(10):1138-46. DOI: 10.1097/GME.0000000000000487. View

11.

Li K, Fan F, Zheng B, Jia J, Liu B, Liu J . Associations between remnant lipoprotein cholesterol and central systolic blood pressure in a Chinese community-based population: a cross-sectional study. Lipids Health Dis. 2021; 20(1):60. PMC: 8235613. DOI: 10.1186/s12944-021-01490-0. View

12.

Ambikairajah A, Walsh E, Tabatabaei-Jafari H, Cherbuin N . Fat mass changes during menopause: a metaanalysis. Am J Obstet Gynecol. 2019; 221(5):393-409.e50. DOI: 10.1016/j.ajog.2019.04.023. View

13.

Faridi K, Quispe R, Martin S, Hendrani A, Joshi P, Brinton E . Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids. J Clin Lipidol. 2019; 13(4):634-644. DOI: 10.1016/j.jacl.2019.06.001. View

14.

Rizvi A, Pantea Stoian A, Janez A, Rizzo M . Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options. Biomedicines. 2021; 9(11). PMC: 8615620. DOI: 10.3390/biomedicines9111579. View

15.

Rizvi A, Pantea Stoian A, Rizzo M . Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies. Int J Mol Sci. 2021; 22(18). PMC: 8470871. DOI: 10.3390/ijms221810038. View

16.

Lindsay R, Howard B . Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep. 2004; 4(1):63-8. DOI: 10.1007/s11892-004-0013-9. View

17.

Rizzo M, Pernice V, Frasheri A, Di Lorenzo G, Rini G, Spinas G . Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrinol (Oxf). 2008; 70(6):870-5. DOI: 10.1111/j.1365-2265.2008.03407.x. View

18.

Stefanska A, Bergmann K, Sypniewska G . Metabolic Syndrome and Menopause: Pathophysiology, Clinical and Diagnostic Significance. Adv Clin Chem. 2015; 72:1-75. DOI: 10.1016/bs.acc.2015.07.001. View

19.

Ford E . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28(7):1769-78. DOI: 10.2337/diacare.28.7.1769. View

20.

Yan P, Xu Y, Miao Y, Bai X, Wu Y, Tang Q . Association of remnant cholesterol with chronic kidney disease in middle-aged and elderly Chinese: a population-based study. Acta Diabetol. 2021; 58(12):1615-1625. DOI: 10.1007/s00592-021-01765-z. View